Literature DB >> 27364555

Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells.

Chun-Ting Cheng1, Ching-Ying Kuo2, Ching Ouyang3, Chien-Feng Li4, Yiyin Chung2, David C Chan5, Hsing-Jien Kung6, David K Ann7.   

Abstract

Mitochondrial dynamics during nutrient starvation of cancer cells likely exert profound effects on their capability for metastatic progression. Here, we report that KAP1 (TRIM28), a transcriptional coadaptor protein implicated in metastatic progression in breast cancer, is a pivotal regulator of mitochondrial fusion in glucose-starved cancer cells. Diverse metabolic stresses induced Ser473 phosphorylation of KAP1 (pS473-KAP1) in a ROS- and p38-dependent manner. Results from live-cell imaging and molecular studies revealed that during the first 6 to 8 hours of glucose starvation, mitochondria initially underwent extensive fusion, but then subsequently fragmented in a pS473-KAP1-dependent manner. Mechanistic investigations using phosphorylation-defective mutants revealed that KAP1 Ser473 phosphorylation limited mitochondrial hyperfusion in glucose-starved breast cancer cells, as driven by downregulation of the mitofusin protein MFN2, leading to reduced oxidative phosphorylation and ROS production. In clinical specimens of breast cancer, reduced expression of MFN2 corresponded to poor prognosis in patients. In a mouse xenograft model of human breast cancer, there was an association in the core region of tumors between MFN2 downregulation and the presence of highly fragmented mitochondria. Collectively, our results suggest that KAP1 Ser473 phosphorylation acts through MFN2 reduction to restrict mitochondrial hyperfusion, thereby contributing to cancer cell survival under conditions of sustained metabolic stress. Cancer Res; 76(17); 5006-18. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27364555      PMCID: PMC5316485          DOI: 10.1158/0008-5472.CAN-15-2921

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  Glutamine and cancer: cell biology, physiology, and clinical opportunities.

Authors:  Christopher T Hensley; Ajla T Wasti; Ralph J DeBerardinis
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

3.  Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway.

Authors:  Yael Ziv; Dana Bielopolski; Yaron Galanty; Claudia Lukas; Yoichi Taya; David C Schultz; Jiri Lukas; Simon Bekker-Jensen; Jiri Bartek; Yosef Shiloh
Journal:  Nat Cell Biol       Date:  2006-07-23       Impact factor: 28.824

4.  Distinct roles of ATR and DNA-PKcs in triggering DNA damage responses in ATM-deficient cells.

Authors:  Nozomi Tomimatsu; Bipasha Mukherjee; Sandeep Burma
Journal:  EMBO Rep       Date:  2009-05-15       Impact factor: 8.807

5.  Role of mitofusin 2 (Mfn2) in controlling cellular proliferation.

Authors:  Kuang-Hueih Chen; Asish Dasgupta; Jinhui Ding; Fred E Indig; Paritosh Ghosh; Dan L Longo
Journal:  FASEB J       Date:  2013-09-30       Impact factor: 5.191

6.  Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.

Authors:  Fuming Qiu; Yun-Ru Chen; Xiyong Liu; Cheng-Ying Chu; Li-Jiuan Shen; Jinghong Xu; Shikha Gaur; Henry Jay Forman; Hang Zhang; Shu Zheng; Yun Yen; Jian Huang; Hsing-Jien Kung; David K Ann
Journal:  Sci Signal       Date:  2014-04-01       Impact factor: 8.192

7.  Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia.

Authors:  Hsiu-Ni Kung; Jeffrey R Marks; Jen-Tsan Chi
Journal:  PLoS Genet       Date:  2011-08-11       Impact factor: 5.917

8.  During autophagy mitochondria elongate, are spared from degradation and sustain cell viability.

Authors:  Ligia C Gomes; Giulietta Di Benedetto; Luca Scorrano
Journal:  Nat Cell Biol       Date:  2011-04-10       Impact factor: 28.824

9.  Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation.

Authors:  Prashant Mishra; Valerio Carelli; Giovanni Manfredi; David C Chan
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

10.  Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype.

Authors:  Yong Fu; Zobeida Cruz-Monserrate; H Helen Lin; Yiyin Chung; Baoan Ji; Szu-Min Lin; Steven Vonderfecht; Craig D Logsdon; Chien-Feng Li; David K Ann
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

View more
  24 in total

Review 1.  Estrogens regulate life and death in mitochondria.

Authors:  Carolyn M Klinge
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

2.  Autophagic reliance promotes metabolic reprogramming in oncogenic KRAS-driven tumorigenesis.

Authors:  H Helen Lin; Yiyin Chung; Chun-Ting Cheng; Ching Ouyang; Yong Fu; Ching-Ying Kuo; Kevin K Chi; Maryam Sadeghi; Peiguo Chu; Hsing-Jien Kung; Chien-Feng Li; Kirsten H Limesand; David K Ann
Journal:  Autophagy       Date:  2018-08-21       Impact factor: 16.016

3.  Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.

Authors:  Longlong Xie; Feng Shi; Yueshuo Li; We Li; Xinfang Yu; Lin Zhao; Min Zhou; Jianmin Hu; Xiangjian Luo; Min Tang; Jia Fan; Jian Zhou; Qiang Gao; Weizhong Wu; Xin Zhang; Weihua Liao; Ann M Bode; Ya Cao
Journal:  Signal Transduct Target Ther       Date:  2020-05-20

Review 4.  Mitochondrial dynamics regulators: implications for therapeutic intervention in cancer.

Authors:  Sanjay Kumar; Rahail Ashraf; Aparna C K
Journal:  Cell Biol Toxicol       Date:  2021-10-18       Impact factor: 6.691

5.  Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells.

Authors:  Youngjin Han; Boyun Kim; Untack Cho; In Sil Park; Se Ik Kim; Danny N Dhanasekaran; Benjamin K Tsang; Yong Sang Song
Journal:  Oncogene       Date:  2019-08-13       Impact factor: 9.867

6.  Genome-wide CRISPR/Cas9 knockout screening uncovers a novel inflammatory pathway critical for resistance to arginine-deprivation therapy.

Authors:  Cheng-Ying Chu; Yi-Ching Lee; Cheng-Han Hsieh; Chi-Tai Yeh; Tsu-Yi Chao; Po-Hung Chen; I-Hsuan Lin; Tsung-Han Hsieh; Jing-Wen Shih; Chia-Hsiung Cheng; Che-Chang Chang; Ping-Sheng Lin; Yuan-Li Huang; Tsung-Ming Chen; Yun Yen; David K Ann; Hsing-Jien Kung
Journal:  Theranostics       Date:  2021-01-25       Impact factor: 11.556

Review 7.  Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis.

Authors:  Mary Adebayo; Seema Singh; Ajay Pratap Singh; Santanu Dasgupta
Journal:  FASEB J       Date:  2021-06       Impact factor: 5.834

8.  Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.

Authors:  Danchen Wu; Asish Dasgupta; Austin D Read; Rachel E T Bentley; Mehras Motamed; Kuang-Hueih Chen; Ruaa Al-Qazazi; Jeffrey D Mewburn; Kimberly J Dunham-Snary; Elahe Alizadeh; Lian Tian; Stephen L Archer
Journal:  Free Radic Biol Med       Date:  2021-01-12       Impact factor: 8.101

9.  MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling.

Authors:  Ke Xu; Guo Chen; Xiaobo Li; Xiaoqin Wu; Zhijie Chang; Jianhua Xu; Yu Zhu; Peihao Yin; Xin Liang; Lei Dong
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

10.  HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia.

Authors:  Xinyan Li; Mengshen Wang; Su Li; Yuqiong Chen; Mozhi Wang; Zhonghua Wu; Xiangyu Sun; Litong Yao; Haoran Dong; Yongxi Song; Yingying Xu
Journal:  Theranostics       Date:  2021-05-25       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.